American Journal of Epidemiology Vol. 142, No. 8: 820-827
Copyright © 1995 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
The Frequency of Idiopathic Parkinson's Disease by Age, Ethnic Group, and Sex in Northern Manhattan, 19881993
1Department of Neurology, College of Physicians and Surgeons, Columbia University New York, NY.
2Department of Psychiatry, College of Physicians and Surgeons, Columbia University New York, NY.
3Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University New York, NY.
4Division of Epidemiology, School of Public Health, Columbia University New York, NY.
5Department of Medicine, College of Physicians and Surgeons, Columbia University New York, NY.
6Center for Geriatrics and Gerontology, College of Physicians and Surgeons, Columbia University New York, NY.
Reprint requests to Dr. Richard Mayeux, The Gertrude H. Sergievsky Center, 630 West 168th Street, New York, NY 10032.
Sex and ethnic differences in the frequency of Parkinson's disease have become increasingly important, because putative genetic and environmental risk factors have been identified. The authors estimated the prevalence and incidence of Parkinson's disease in a culturally diverse community in New York City over a 4-year period (January 1, 1988December 31, 1991) using a disease registry substantiated, for older individuals, by a subsequent survey of a random sample of Medicare recipients between January 1, 1992, and December 31, 1993. The prevalence rate was 107 per 100,000 persons, and over a 3-year period the average incidence rate was 13 per 100,000 person-years. Age-adjusted prevalence rates were lower for women than for men in each ethnic group and were lower for blacks than for whites and Hispanics. Incidence rates were highest among black men, but they were otherwise comparable across the sex and ethnic groups. The estimated cumulative incidence of Parkinson's disease up to age 90 years was lower for women than for men, which could partially explain the lower prevalence rate. By ethnic group, the cumulative incidence was higher for blacks than for whites and Hispanics, but more deaths occurred among incident black cases. Discrepant prevalence and incidence rates of Parkinson's disease among blacks and women warrant further investigation. While selective mortality could partially account for this paradox, it is also possible that a delay in diagnosis due to limited access to appropriate health services among these individuals could have resulted in the observed discordant rates of disease.
aging; ethnic groups; incidence; prevalence; Parkinson disease; sex
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Y. Lo, C. M. Tanner, K. B. Albers, A. D. Leimpeter, R. D. Fross, A. L. Bernstein, V. McGuire, C. P. Quesenberry, L. M. Nelson, and S. K. Van Den Eeden Clinical Features in Early Parkinson Disease and Survival Arch Neurol, November 1, 2009; 66(11): 1353 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Alves, B Muller, K Herlofson, I HogenEsch, W Telstad, D Aarsland, O-B Tysnes, J P Larsen, and for the Norwegian ParkWest study group Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study J. Neurol. Neurosurg. Psychiatry, August 1, 2009; 80(8): 851 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. O'Brien, V. Wadley, A. P. Nicholas, N. P. Stover, R. Watts, and H. R. Griffith The Contribution of Executive Control on Verbal-Learning Impairment in Patients with Parkinson's Disease with Dementia and Alzheimer's Disease Arch Clin Neuropsychol, July 8, 2009; (2009) acp029v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Driver, G. Logroscino, J. M. Gaziano, and T. Kurth Incidence and remaining lifetime risk of Parkinson disease in advanced age Neurology, February 3, 2009; 72(5): 432 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. DelleDonne, K. J. Klos, H. Fujishiro, Z. Ahmed, J. E. Parisi, K. A. Josephs, R. Frigerio, M. Burnett, Z. K. Wszolek, R. J. Uitti, et al. Incidental Lewy Body Disease and Preclinical Parkinson Disease Arch Neurol, August 1, 2008; 65(8): 1074 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Gao, H. Chen, H. K. Choi, G. Curhan, M. A. Schwarzschild, and A. Ascherio Diet, Urate, and Parkinson's Disease Risk in Men Am. J. Epidemiol., April 1, 2008; 167(7): 831 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Louis, N. Schupf, M. X. Tang, K. Marder, and J. A. Luchsinger Mild Parkinsonian Signs and Plasma Homocysteine Concentration in Community-Dwelling Elderly Individuals Arch Neurol, November 1, 2007; 64(11): 1646 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ritz, A. Ascherio, H. Checkoway, K. S. Marder, L. M. Nelson, W. A. Rocca, G. W. Ross, D. Strickland, S. K. Van Den Eeden, and J. Gorell Pooled Analysis of Tobacco Use and Risk of Parkinson Disease Arch Neurol, July 1, 2007; 64(7): 990 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, L. N. Clark, K. Marder, and D. Rabinowitz Nonparametric estimation of age-at-onset distributions from censored kin-cohort data Biometrika, June 1, 2007; 94(2): 403 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hirtz, D. J. Thurman, K. Gwinn-Hardy, M. Mohamed, A. R. Chaudhuri, and R. Zalutsky How common are the "common" neurologic disorders? Neurology, January 30, 2007; 68(5): 326 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Louis and J. A. Luchsinger History of vascular disease and mild parkinsonian signs in community-dwelling elderly individuals. Arch Neurol, May 1, 2006; 63(5): 717 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Baba, K. Markopoulou, J. D. Putzke, N. R. Whaley, M. J. Farrer, Z. K. Wszolek, and R. J. Uitti Phenotypic commonalities in familial and sporadic Parkinson disease. Arch Neurol, April 1, 2006; 63(4): 579 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Popat, S. K. Van Den Eeden, C. M. Tanner, V. McGuire, A. L. Bernstein, D. A. Bloch, A. Leimpeter, and L. M. Nelson Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease Neurology, August 9, 2005; 65(3): 383 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Barnes, R. S. Wilson, J. L. Bienias, J. A. Schneider, D. A. Evans, and D. A. Bennett Sex Differences in the Clinical Manifestations of Alzheimer Disease Pathology Arch Gen Psychiatry, June 1, 2005; 62(6): 685 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Benito-Leon, F. Bermejo-Pareja, E. D. Louis, and for the Neurological Disorders in Central Spain (N Incidence of essential tremor in three elderly populations of central Spain Neurology, May 24, 2005; 64(10): 1721 - 1725. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Louis, N. Schupf, J. Manly, K. Marder, M. X. Tang, and R. Mayeux Association between mild parkinsonian signs and mild cognitive impairment in a community Neurology, April 12, 2005; 64(7): 1157 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Louis, M. X. Tang, N. Schupf, and R. Mayeux Functional Correlates and Prevalence of Mild Parkinsonian Signs in a Community Population of Older People Arch Neurol, February 1, 2005; 62(2): 297 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M.L. de Lau, P. C.L.M. Giesbergen, M. C. de Rijk, A. Hofman, P. J. Koudstaal, and M. M.B. Breteler Incidence of parkinsonism and Parkinson disease in a general population: The Rotterdam Study Neurology, October 12, 2004; 63(7): 1240 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Louis, M. X. Tang, and R. Mayeux Parkinsonian Signs in Older People in a Community-Based Study: Risk of Incident Dementia Arch Neurol, August 1, 2004; 61(8): 1273 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Nathan, A. G. Barsukova, F. Shen, M. McAsey, and R. G. Struble Estrogen Facilitates Neurite Extension via Apolipoprotein E in Cultured Adult Mouse Cortical Neurons Endocrinology, July 1, 2004; 145(7): 3065 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C.S. Tan, N. Venketasubramanian, C. Y. Hong, S. Sahadevan, J. J. Chin, E. S. Krishnamoorthy, A. K.Y. Tan, and S. M. Saw Prevalence of Parkinson disease in Singapore: Chinese vs Malays vs Indians Neurology, June 8, 2004; 62(11): 1999 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ragonese, M. D'Amelio, G. Salemi, P. Aridon, M. Gammino, A. Epifanio, L. Morgante, and G. Savettieri Risk of Parkinson disease in women: Effect of reproductive characteristics Neurology, June 8, 2004; 62(11): 2010 - 2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
G F Wooten, L J Currie, V E Bovbjerg, J K Lee, and J Patrie Are men at greater risk for Parkinson's disease than women? J. Neurol. Neurosurg. Psychiatry, April 1, 2004; 75(4): 637 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, S. M. Zhang, M. A. Schwarzschild, M. A. Hernan, W. C. Willett, and A. Ascherio Obesity and the Risk of Parkinson's Disease Am. J. Epidemiol., March 15, 2004; 159(6): 547 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Benito-Leon, F. Bermejo-Pareja, J. M. Morales-Gonzalez, J. Porta-Etessam, R. Trincado, S. Vega, and E. D. Louis Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain Neurology, March 9, 2004; 62(5): 734 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Foltynie, C. E. G. Brayne, T. W. Robbins, and R. A. Barker The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study Brain, March 1, 2004; 127(3): 550 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fischer, R. Bozanovic-Sosic, and M. Norris Review of delusions in dementia American Journal of Alzheimer's Disease and Other Dementias, January 1, 2004; 19(1): 19 - 23. [Abstract] [PDF] |
||||
![]() |
M. Schiess Nonsteroidal Anti-inflammatory Drugs Protect Against Parkinson Neurodegeneration: Can an NSAID a Day Keep Parkinson Disease Away? Arch Neurol, August 1, 2003; 60(8): 1043 - 1044. [Full Text] [PDF] |
||||
![]() |
E. D. Louis, J. A. Luchsinger, M. X. Tang, and R. Mayeux Parkinsonian signs in older people: Prevalence and associations with smoking and coffee Neurology, July 8, 2003; 61(1): 24 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Van Den Eeden, C. M. Tanner, A. L. Bernstein, R. D. Fross, A. Leimpeter, D. A. Bloch, and L. M. Nelson Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity Am. J. Epidemiol., June 1, 2003; 157(11): 1015 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.M. Ravina, S.C. Fagan, R.G. Hart, C.A. Hovinga, D.D. Murphy, T.M. Dawson, and J.R. Marler Neuroprotective agents for clinical trials in Parkinson's disease: A systematic assessment Neurology, April 22, 2003; 60(8): 1234 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ascherio, H. Chen, M.A. Schwarzschild, S.M. Zhang, G.A. Colditz, and F.E. Speizer Caffeine, postmenopausal estrogen, and risk of Parkinson's disease Neurology, March 11, 2003; 60(5): 790 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Siderowf, B. Ravina, and H. A. Glick Preference-based quality-of-life in patients with Parkinson's disease Neurology, July 9, 2002; 59(1): 103 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Simon, M. Lin, and A Pascual-Leone "Nature versus nurture" and incompletely penetrant mutations J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 686 - 689. [Full Text] [PDF] |
||||
![]() |
H. Checkoway, K. Powers, T. Smith-Weller, G. M. Franklin, W. T. Longstreth Jr., and P. D. Swanson Parkinson's Disease Risks Associated with Cigarette Smoking, Alcohol Consumption, and Caffeine Intake Am. J. Epidemiol., April 15, 2002; 155(8): 732 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Tanner, S. M. Goldman, D. A. Aston, R. Ottman, J. Ellenberg, R. Mayeux, and J. W. Langston Smoking and Parkinson's disease in twins Neurology, February 26, 2002; 58(4): 581 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Piccini, J. de Yebenez, A. J. Lees, R. Ceravolo, N. Turjanski, P. Pramstaller, and D. J. Brooks Familial Progressive Supranuclear Palsy: Detection of Subclinical Cases Using 18F-Dopa and 18Fluorodeoxyglucose Positron Emission Tomography Arch Neurol, November 1, 2001; 58(11): 1846 - 1851. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Baldereschi, A. Di Carlo, W. A. Rocca, P. Vanni, S. Maggi, E. Perissinotto, F. Grigoletto, L. Amaducci, and D. Inzitari Parkinson's disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men Neurology, November 14, 2000; 55(9): 1358 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Tomik, A Nicotra, C M Ellis, C Murphy, S Rabe-Hesketh, M Parton, C E Shaw, and P N Leigh Phenotypic differences between African and white patients with motor neuron disease: a case-control study J. Neurol. Neurosurg. Psychiatry, August 1, 2000; 69(2): 251 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. SAWADA, M. IBI, T. KIHARA, M. URUSHITANI, K. HONDA, M. NAKANISHI, A. AKAIKE, and S. SHIMOHAMA Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons FASEB J, June 1, 2000; 14(9): 1202 - 1214. [Abstract] [Full Text] |
||||
![]() |
H. Jacobs, P. Vieregge, K. Marder, M. Tang, E. Louis, and R. Mayeux Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia Neurology, March 14, 2000; 54(5): 1208 - 1209. [Full Text] [PDF] |
||||
![]() |
J. P. Kelly Traumatic Brain Injury and Concussion in Sports JAMA, September 8, 1999; 282(10): 989 - 991. [Full Text] [PDF] |
||||
![]() |
E. D. Louis, M. X. Tang, L. Cote, B. Alfaro, H. Mejia, and K. Marder Progression of Parkinsonian Signs in Parkinson Disease Arch Neurol, March 1, 1999; 56(3): 334 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Marder, M.-X. Tang, B. Alfaro, H. Mejia, L. Cote, E. Louis, Y. Stern, and R. Mayeux Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia Neurology, March 1, 1999; 52(4): 719 - 719. [Abstract] [Full Text] |
||||
![]() |
C. M. Tanner, R. Ottman, S. M. Goldman, J. Ellenberg, P. Chan, R. Mayeux, and J. W. Langston Parkinson Disease in Twins: An Etiologic Study JAMA, January 27, 1999; 281(4): 341 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Litvan Parkinsonian Features: When Are They Parkinson Disease? JAMA, November 18, 1998; 280(19): 1654 - 1655. [Full Text] [PDF] |
||||
![]() |
I. Litvan, A. MacIntyre, C. G. Goetz, G. K. Wenning, K. Jellinger, M. Verny, J. J. Bartko, J. Jankovic, A. McKee, J. P. Brandel, et al. Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies: A Clinicopathologic Study Arch Neurol, July 1, 1998; 55(7): 969 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Mitchell, E. A. Sullivan, and L. A. Lipsitz Exclusion of Elderly Subjects From Clinical Trials for Parkinson Disease Arch Neurol, November 1, 1997; 54(11): 1393 - 1398. [Abstract] [PDF] |
||||
![]() |
I. Litvan, C. G. Goetz, J. Jankovic, G. K. Wenning, V. Booth, J. J. Bartko, A. McKee, K. Jellinger, E. C. Lai, J.-P. Brandel, et al. What Is the Accuracy of the Clinical Diagnosis of Multiple System Atrophy? A Clinicopathologic Study Arch Neurol, August 1, 1997; 54(8): 937 - 944. [Abstract] [PDF] |
||||
![]() |
E. D. Louis, K. Marder, L. Cote, M. Tang, and R. Mayeux Mortality From Parkinson Disease Arch Neurol, March 1, 1997; 54(3): 260 - 264. [Abstract] [PDF] |
||||











